A Phase 3b, Randomized, Double Blind, Placebo Controlled

Project: Research project

Project Details


Protocol #6517-CL-0020, Phase 3b Study to Evaluate the Safety and Efficacy of Vernakalant Hydrochloride Injections
Effective start/end date2/1/101/19/12


  • Astellas Pharma US, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.